Enhanced insulin sensitivity in mice lacking ganglioside GM3
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Gangliosides are sialic acid-containing glycosphingolipids that are present on all mammalian plasma membranes where they participate in recognition and signaling activities. We have established mutant mice that lack GM3 synthase (CMP-NeuAc:lactosylceramide α2,3-sialyltransferase; EC 2.4.99.-). These mutant mice were unable to synthesize GM3 ganglioside, a simple and widely distributed glycosphingolipid. The mutant mice were viable and appeared without major abnormalities but showed a heightened sensitivity to insulin. A basis for the increased insulin sensitivity in the mutant mice was found to be enhanced insulin receptor phosphorylation in skeletal muscle. Importantly, the mutant mice were protected from high-fat diet-induced insulin resistance. Our results show that GM3 ganglioside is a negative regulator of insulin signaling, making it a potential therapeutic target in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and elimination of GM3 affects insulin receptor action (405, 523 -524).”
From Biological roles of glycans (2017) · cites this paper as [405]
Citations
Cites
Lipid rafts and signal transduction
Simons, K., & Toomre, D. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35036052 · Cited by 5,371
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Anderson, R. G. W. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.199 · Cited by 1,942
Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Moller, D. E. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00272-1 · Cited by 718
New Perspectives into the Molecular Pathogenesis and Treatment of Type 2 Diabetes
Saltiel, A. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00239-2 · Cited by 692
Hakomori, S.-I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012540899 · Cited by 492
Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance
Tagami, S., Inokuchi, J.-I., Kabayama, K., Yoshimura, H., Kitamura, F., Uemura, S., Ogawa, C., Ishii, A., Saito, M., Ohtsuka, Y., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103705200 · Cited by 355
Kim, J. K., Michael, M. D., Previs, S. F., Peroni, O. D., Mauvais-Jarvis, F., Neschen, S., Kahn, B. B., Kahn, C. R., & Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8305 · Cited by 331
Combinatorial Ganglioside Biosynthesis
Kolter, T., Proia, R. L., & Sandhoff, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200001200 · Cited by 322
Self-citation
Cited by
Items 101–200 of 573
The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice
Sapra, G., Tham, Y. K., Cemerlang, N., Matsumoto, A., Kiriazis, H., Bernardo, B. C., Henstridge, D. C., Ooi, J. Y. Y., Pretorius, L., Boey, E. J. H., et al. (2014) · Nature Communications · doi:10.1038/ncomms6705 · Cited by 113
Glucocerebrosidase: Functions in and Beyond the Lysosome
Boer, D. E. C., van Smeden, J., Bouwstra, J. A., & Aerts, J. M. F. G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030736 · Cited by 114
Diabetes Alters Sphingolipid Metabolism in the Retina
Fox, T. E., Han, X., Kelly, S. L., Merrill, A. H., Martin, R. E., Anderson, R. E., Gardner, T. W., & KESTER, M. A. (2006) · Diabetes · doi:10.2337/db06-0539 · Cited by 111
Tamboli, I. Y., Prager, K., Barth, E., Heneka, M., Sandhoff, K., & Walter, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414525200 · Cited by 110
Self-citationHirahara, Y., Bansal, R., Honke, K., Ikenaka, K., & Wada, Y. (2004) · Glia · doi:10.1002/glia.10327 · Cited by 96
Wennekes, T., Meijer, A. J., Groen, A. K., Boot, R. G., Groener, J. E. M., van Eijk, M., Ottenhoff, R., Bijl, N., der Vlugt, K. G., Song, H., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901281m · Cited by 107
Targeting ceramide metabolism in obesity
Aburasayn, H., Al Batran, R., & Ussher, J. R. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00133.2016 · Cited by 96
Novel Insights and Mechanisms of Lipotoxicity-Driven Insulin Resistance
Lair, B., Laurens, C., Bosch, B. V. D., & Moro, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176358 · Cited by 107
On ceramides, other sphingolipids and impaired glucose homeostasis
Larsen, P. J., & Tennagels, N. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.011 · Cited by 93
Gender, Contraceptives and Individual Metabolic Predisposition Shape a Healthy Plasma Lipidome
Sales, S., Graessler, J., Ciucci, S., Al-Atrib, R., Vihervaara, T., Schuhmann, K., Kauhanen, D., Sysi-Aho, M., Bornstein, S. R., Bickle, M., et al. (2016) · Scientific Reports · doi:10.1038/srep27710 · Cited by 103
Influence of dietary gangliosides on neonatal brain development
McJarrow, P., Schnell, N., Jumpsen, J., & Clandinin, T. M. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00211.x · Cited by 102
Glycosphingolipid–Protein Interaction in Signal Transduction
Russo, D., Parashuraman, S., & D’Angelo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101732 · Cited by 102
Sialylation regulates brain structure and function
Yoo, S., Motari, M. G., Susuki, K., Prendergast, J., Mountney, A., Hurtado, A., & Schnaar, R. L. (2015) · The FASEB Journal · doi:10.1096/fj.15-270983 · Cited by 101
Bijl, N., Sokolović, M., Vrins, C., Langeveld, M., Moerland, P. D., Ottenhoff, R., van Roomen, C. P. A. A., Claessen, N., Boot, R. G., Aten, J., et al. (2009) · Hepatology · doi:10.1002/hep.23175 · Cited by 92
What Have We Learned from Glycosyltransferase Knockouts in Mice?
Stanley, P. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.03.025 · Cited by 97
Glycosylation of Glycolipids in Cancer: Basis for Development of Novel Therapeutic Approaches
Daniotti, J. L., Vilcaes, A. A., Demichelis, V. T., Ruggiero, F. M., & Rodríguez‐Walker, M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00306 · Cited by 96
Self-citationWendeler, M., & Sandhoff, K. (2008) · Glycoconjugate Journal · doi:10.1007/s10719-008-9137-5 · Cited by 96
Self-citationGanglioside GM3 and its biological functions
Prokazova, N. V., Samovilova, N. N., Gracheva, E. V., & Golovanova, N. K. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909030018 · Cited by 95
Sphingolipid metabolism in non-alcoholic fatty liver diseases
Régnier, M., Polizzi, A., Guillou, H., & Loiseau, N. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.021 · Cited by 95
Sphingolipid Metabolism and Signaling in Skeletal Muscle: From Physiology to Physiopathology
Tan, S., Guitton, J., Bourron, O., Stunff, H. L., & Hajduch, É. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00491 · Cited by 94
Glycan Antagonists and Inhibitors: A Fount for Drug Discovery
Brown, J. R., Crawford, B. E., & Esko, J. D. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701751611 · Cited by 99
Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice #
Zhao, H., Przybylska, M., Wu, I.-H., Zhang, J., Maniatis, P., Pacheco, J., Piepenhagen, P., Copeland, D., Arbeeny, C., Shayman, J. A., et al. (2009) · Hepatology · doi:10.1002/hep.22970 · Cited by 88
Hermo, L., Pelletier, R. ‐., Cyr, D. G., & Smith, C. E. (2009) · Microscopy Research and Technique · doi:10.1002/jemt.20786 · Cited by 93
Membrane rafting: From apical sorting to phase segregation
Coskun, Ü., & Simons, K. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.12.043 · Cited by 91
Novel Class of Glycosphingolipids Involved in Male Fertility
Sandhoff, R., Geyer, R., Jennemann, R., Paret, C., Kiss, E., Yamashita, T., Gorgas, K., Sijmonsma, T. P., Iwamori, M., Finaz, C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502775200 · Cited by 89
Self-citationGanglioside GM3 is involved in neuronal cell death
Sohn, H., Kim, Y.-S., Kim, H.-T., Kim, C., Cho, E., Kang, H., Kim, N.-S., Kim, C., Ryu, S. E., Lee, J. H., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4911fje · Cited by 87
Ramirez, T., Longato, L., Dostalek, M., Tong, M., Wands, J. R., & de la Monte, S. M. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/ags106 · Cited by 82
Type I Gaucher Disease, a Glycosphingolipid Storage Disorder, Is Associated with Insulin Resistance
Langeveld, M., Ghauharali, K. J. M., Sauerwein, H. P., Ackermans, M. T., Groener, J. E. M., Hollak, C. E. M., Aerts, J. M., & Serlie, M. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1702 · Cited by 82
Glycosphingolipids and mitochondria: Role in apoptosis and disease
Morales, A., Colell, A., Marí, M., García‐Ruiz, C., & Fernández-Checa, J. C. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000043294.62504.2c · Cited by 86
der Vlugt, K. G., Langeveld, M., Poppema, A., Kuiper, S., Hollak, C. E. M., Aerts, J. M. F. G., & Groener, J. E. M. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.12.001 · Cited by 85
Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance
Lipina, C., & Hundal, H. S. (2011) · Diabetologia · doi:10.1007/s00125-011-2127-3 · Cited by 83
“Furthermore, GM3 itself can mimic the effects of TNFα by inhibiting tyrosine phosphorylation of the insulin receptor and IRS-1, as well as suppressing insulinstimulated glucose uptake [89, 91].”
BackgroundNakamura, K. M., Suzuki, Y., Goto‐Inoue, N., Yoshida, C., & Suzuki, A. (2006) · Analytical Chemistry · doi:10.1021/ac0605501 · Cited by 82
Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease
Aerts, J. M. F. G., Kuo, C. J., Lelieveld, L. T., Boer, D. E. C., van der Lienden, M. J. C., Overkleeft, H. S., & Artola, M. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.10.006 · Cited by 81
Functions of sphingolipid metabolism in mammals — Lessons from genetic defects
Sabourdy, F., Kedjouar, B., Sorli, S., Colié, S., Milhas, D., Salma, Y., & Levade, T. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.01.004 · Cited by 81
Golgi Glycosylation and Human Inherited Diseases
Freeze, H. H., & Ng, B. G. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a005371 · Cited by 81
Ganglioside Metabolism in Health and Disease
Sandhoff, R., Schulze, H., & Sandhoff, K. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.01.002 · Cited by 80
Self-citationHodges, A., Hughes, G., Brooks, S., Elliston, L., Holmans, P., Dunnett, S. B., & Jones, L. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00350.x · Cited by 69
The nutritional and clinical significance of lipid rafts
Yaqoob, P., & Shaikh, S. R. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328335725b · Cited by 76
Lipid-mediated muscle insulin resistance: different fat, different pathways?
Ritter, O., Jelenik, T., & Roden, M. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1310-2 · Cited by 74
“On the other hand, in vivo pharmacological and genetic inhibition of GM3 in mice enhanced insulin signaling and prevented from HFD-induced IR in muscle [87, 88].”
BackgroundJennemann, R., & Gröne, H. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.02.001 · Cited by 74
Identification of host cell factors required for intoxication through use of modified cholera toxin
Guimaraes, C. P., Carette, J. E., Varadarajan, M., Antos, J., Popp, M. W., Spooner, E., Brummelkamp, T. R., & Ploegh, H. L. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201108103 · Cited by 66
Shui, G., Stebbins, J. W., Lam, B. D., Cheong, W. F., Lam, S. M., Gregoire, F., Kusonoki, J., & Wenk, M. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019731 · Cited by 68
Zeb1 affects epithelial cell adhesion by diverting glycosphingolipid metabolism
Mathow, D., Chessa, F., Rabionet, M., Kaden, S., Jennemann, R., Sandhoff, R., Gröne, H., & Feuerborn, A. (2015) · EMBO Reports · doi:10.15252/embr.201439333 · Cited by 73
Self-citationNordström, V., Willershäuser, M., Herzer, S., Rozman, J., Halbach, O. V. B. U., Meldner, S., Rothermel, U., Kaden, S., Roth, F. C., Waldeck, C., et al. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001506 · Cited by 72
A role for phosphatidylcholine and phosphatidylethanolamine in hepatic insulin signaling
van der Veen, J. N., Lingrell, S., McCloskey, N. S., LeBlond, N. D., Galleguillos, D., Zhao, Y., Curtis, J. M., Sipione, S., Fullerton, M. D., Vance, D. E., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802117r · Cited by 72
Caveolins and Caveolae, Roles in Insulin Signalling and Diabetes
Strålfors, P. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-1222-9_8 · Cited by 71
Miura, Y., Kainuma, M., Jiang, H., Velasco, H., Vogt, P. K., & Hakomori, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407297101 · Cited by 70
Miao, H., Li, B., Wang, Z., Mu, J., Tian, Y., Jiang, B., Zhang, S., Gong, X., Shui, G., & Lam, S. M. (2022) · Research · doi:10.34133/research.0006 · Cited by 70
Marimuthu, S., Korrapati, M. C., Howell, L. A., Arthur, J. M., Shayman, J. A., Schnellmann, R. G., & Siskind, L. J. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00150.2015 · Cited by 70
Pleiotropic effects of sphingolipids in skeletal muscle
Bruni, P., & Donati, C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8236-6 · Cited by 70
Membrane microdomains and insulin resistance
Inokuchi, J. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.012 · Cited by 70
Inokuchi, J., Inamori, K., Kabayama, K., Nagafuku, M., Uemura, S., Go, S., Suzuki, A., Ohno, I., Kanoh, H., & Shishido, F. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.10.004 · Cited by 72
Zhu, Y., Gumlaw, N., Kármán, J., Zhao, H., Zhang, J., Jiang, J.-L., Maniatis, P., Edling, A. E., Chuang, W., Siegel, C., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.218610 · Cited by 69
Adipose Tissue and Ceramide Biosynthesis in the Pathogenesis of Obesity
Samad, F., Badeanlou, L., Shah, C., & Yang, G. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_5 · Cited by 70
Roles of sphingolipids in Drosophila development and disease
Kraut, R. S. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07022.x · Cited by 68
Dennis, J. W., & Brewer, C. F. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r112.026989 · Cited by 68
Mitochondrial involvement in skeletal muscle insulin resistance: A case of imbalanced bioenergetics
Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.07.008 · Cited by 67
Ceramides are fuel gauges on the drive to cardiometabolic disease
Wilkerson, J. L., Tatum, S. M., Holland, W. L., & Summers, S. A. (2024) · Physiological Reviews · doi:10.1152/physrev.00008.2023 · Cited by 67
Lipidomics of Glycosphingolipids
Farwanah, H., & Kolter, T. (2012) · Metabolites · doi:10.3390/metabo2010134 · Cited by 67
Insulin resistance: a connecting link between Alzheimer's disease and metabolic disorder
Kshirsagar, V., Thingore, C., & Juvekar, A. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00622-2 · Cited by 66
“Evidence suggests the positive role of GM3-synthase knockout mice in alleviating insulin signaling impairment (Yamashita et al. 2003).”
BackgroundGlycosphingolipids Are Essential for Intestinal Endocytic Function
Jennemann, R., Kaden, S., Sandhoff, R., Nordström, V., Wang, S., Volz, M., Robine, S., Amen, N., Rothermel, U., Wiegandt, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371005 · Cited by 66
Self-citationMetabolic pathways and intracellular trafficking of gangliosides
Daniotti, J. L., & Iglesias‐Bartolomé, R. (2011) · IUBMB Life · doi:10.1002/iub.477 · Cited by 66
Self-citationDukhinova, M., Kuznetsova, I. S., Kopeikina, E., Veniaminova, E. A., Yung, A. W. Y., Veremeyko, T., Levchuk, K., Barteneva, N. S., Wing-Ho, K. K., Yung, W., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.009 · Cited by 66
Glycosphingolipids and Insulin Resistance
Aerts, J. M. F. G., Boot, R. G., van Eijk, M., Groener, J. E. M., Bijl, N., Lombardo, E., Biétrix, F., Dekker, N., Groen, A. K., Ottenhoff, R., et al. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0650-1_7 · Cited by 66
Yoshizumi, S., Suzuki, S., Hirai, M., Hinokio, Y., Yamada, T., Yamada, T., Tsunoda, U., Aburatani, H., Yamaguchi, K., Miyagi, T., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2006.10.027 · Cited by 66
Lipid Microdomains and Insulin Resistance: Is There a Connection?
Ikonen, E., & Vainio, S. (2005) · Science s STKE · doi:10.1126/stke.2682005pe3 · Cited by 64
Allende, M. L., & Proia, R. L. (2014) · Glycoconjugate Journal · doi:10.1007/s10719-014-9563-5 · Cited by 64
Self-citationSphingolipid signaling in renal fibrosis
Huwiler, A., & Pfeilschifter, J. M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2018.01.006 · Cited by 63
Nagane, M., Yasui, H., Kuppusamy, P., Yamashita, T., & Inanami, O. (2021) · Journal of Radiation Research · doi:10.1093/jrr/rrab032 · Cited by 62
Self-citationGanglioside GM3 as a gatekeeper of obesity‐associated insulin resistance: Evidence and mechanisms
Lipina, C., & Hundal, H. S. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.09.018 · Cited by 57
Beneficial Metabolic Effects of TREM2 in Obesity Are Uncoupled From Its Expression on Macrophages
Sharif, O., Brunner, J. S., Korosec, A., Martins, R., Jais, A., Snijder, B., Vogel, A., Caldera, M., Hladik, A., Lakovits, K., et al. (2021) · Diabetes · doi:10.2337/db20-0572 · Cited by 58
Wang, X.-Q., Sheu, S. L., Wilson, H., Seeger, M., Iordanov, H., Gatla, N., Whittington, A., Bach, D. Q., Lu, J.-Y., & Paller, A. S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.532 · Cited by 61
Homeostatic and pathogenic roles of GM3 ganglioside molecular species in TLR4 signaling in obesity
Kanoh, H., Nitta, T., Go, S., Inamori, K., Veillon, L. J., Nihei, W., Fujii, M., Kabayama, K., Shimoyama, A., Fukase, K., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019101732 · Cited by 61
Bieberich, E. (2004) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000046274.35732.47 · Cited by 61
4GalT6 is involved in the synthesis of lactosylceramide with less intensity than 4GalT5
Tokuda, N., Numata, S., Li, X., Nomura, T., Takizawa, M., Kondo, Y., Yamashita, Y., Hashimoto, N., Kiyono, T., Urano, T., et al. (2013) · Glycobiology · doi:10.1093/glycob/cwt054 · Cited by 60
Recessive GM3 synthase deficiency: Natural history, biochemistry, and therapeutic frontier
Bowser, L. E., Young, M., Wenger, O. K., Ammous, Z., Brigatti, K. W., Carson, V. J., Moser, T., Deline, J., Aoki, K., Morlet, T. G., et al. (2019) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2019.01.013 · Cited by 59
Sphingolipids: the nexus between Gaucher disease and insulin resistance
Fuller, M. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-113 · Cited by 58
Ghisaidoobe, A. B. T., van den Berg, R. J. B. H. N., Butt, S. S., Strijland, A., Donker‐Koopman, W. E., Scheij, S. S., van den Nieuwendijk, A. M. C. H., Koomen, G., van Loevezijn, A., Leemhuis, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501181z · Cited by 58
Sphingolipids in obesity and related complications
Li, P.-L. (2017) · Frontiers in bioscience · doi:10.2741/4474 · Cited by 58
De Novo Sphingolipid Biosynthesis Is Required for Adipocyte Survival and Metabolic Homeostasis
Alexaki, A., Clarke, B. A., Gavrilova, O., Ma, Y., Zhu, H., Ma, X., Xu, L., Tuymetova, G., Larman, B. C., Allende, M. L., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756460 · Cited by 58
Self-citationDaniotti, J. L., Lardone, R. D., & Vilcaes, A. A. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2015.00300 · Cited by 57
Self-citationInvolvement of murine β-1,4-galactosyltransferase V in lactosylceramide biosynthesis
Kumagai, T., SATO, T. A., Natsuka, S., Kobayashi, Y., Zhou, D., Shinkai, T., Hayakawa, S., & Furukawa, K. (2010) · Glycoconjugate Journal · doi:10.1007/s10719-010-9313-2 · Cited by 56
Veillon, L. J., Go, S., Matsuyama, W., Suzuki, A., Nagasaki, M., Yatomi, Y., & Inokuchi, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129645 · Cited by 55
Wennekes, T., Lang, B., Leeman, M., van der Marel, G. A., Smits, E., Weber, M., van Wiltenburg, J., Wolberg, M., Aerts, J. M. F. G., & Overkleeft, H. S. (2008) · Organic Process Research & Development · doi:10.1021/op700295x · Cited by 55
Sphingolipid metabolism in brain insulin resistance and neurological diseases
Mei, M., Liu, M., Mei, Y., Zhao, J., & Li, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1243132 · Cited by 54
A crucial role for T-bet in selectin ligand expression in T helper 1 (Th1) cells
Underhill, G. H., Zisoulis, D. G., Kolli, K. P., Ellies, L. G., Marth, J. D., & Kansas, G. S. (2005) · Blood · doi:10.1182/blood-2005-03-0984 · Cited by 54
New insights in the pathogenesis of non-alcoholic fatty liver disease
Gaemers, I. C., & Groen, A. K. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000226118.43178.98 · Cited by 54
Tajima, O., Egashira, N., Ohmi, Y., Fukue, Y., Mishima, K., Iwasaki, K., Fujiwara, M., Inokuchi, J., Sugiura, Y., Furukawa, K., et al. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.024 · Cited by 53
Miglustat as a therapeutic agent: prospects and caveats
Venier, R. E., & Igdoura, S. A. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101070 · Cited by 53
Porubský, Š., Speak, A. O., Salio, M., Jennemann, R., Bonrouhi, M., Zafarulla, R., Singh, Y., Dyson, J., Luckow, B., Lehuen, A., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201483 · Cited by 53
Genetic diseases of sphingolipid metabolism: Pathological mechanisms and therapeutic options
Kacher, Y., & Futerman, A. H. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.08.041 · Cited by 53
The way we view cellular (glyco)sphingolipids
Hoetzl, S., Sprong, H., & Gerrit van, M. E. E. R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04721.x · Cited by 53
Senda, M., Ito, A., Tsuchida, A., Hagiwara, T., Kaneda, T., Nakamura, Y., Kasama, K., Kiso, M., Yoshikawa, K., Katagiri, Y., et al. (2007) · Biochemical Journal · doi:10.1042/bj20061118 · Cited by 53
Impairment of neuropsychological behaviors in ganglioside GM3-knockout mice
Niimi, K., Nishioka, C., Miyamoto, T., Takahashi, E., Miyoshi, I., Itakura, C., & Yamashita, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.071 · Cited by 52
Self-citationGlycosphingolipids and Infection. Potential New Therapeutic Avenues
Aerts, J. M. F. G., Artola, M., van Eijk, M., Ferraz, M. J., & Boot, R. G. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00324 · Cited by 52
Bui, H. H., Leohr, J. K., & Kuo, M. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.01.027 · Cited by 52
Inokuchi, J. (2014) · Glycoconjugate Journal · doi:10.1007/s10719-013-9516-4 · Cited by 52
Accumulation of Long-Chain Glycosphingolipids during Aging Is Prevented by Caloric Restriction
Hernandez‐Corbacho, M. J., Jenkins, R. W., Clarke, C. J., Hannun, Y. A., Obeid, L. M., Snider, A. J., & Siskind, L. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020411 · Cited by 51
Circulating levels of ganglioside GM3 in metabolic syndrome: A pilot study
Sato, T., Nihei, Y., Nagafuku, M., Tagami, S., Chin, R., Kawamura, M., Miyazaki, S., Suzuki, M., Sugahara, S.-I., Takahashi, Y., et al. (2008) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2008.06.001 · Cited by 50
Ganglioside GM3 promotes cell migration by regulating MAPK and c-Fos/AP-1
Hashiramoto, A., Mizukami, H., & Yamashita, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209416 · Cited by 50
Self-citation
Metadata
- Authors
- Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., Sandhoff, R., Sandhoff, K., & Proia, R. L.
- Affiliations
- National Institutes of Health (US)
- Genetics of Development and Disease and Diabetes Branches, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; Molecular Glycobiology, The Glycoscience Institute, Ochanomizu University, Otsuka, Bunkyo-ku, Tokyo 112-8610, Japan; Centro de Investigaciones en Quimica Biologica de Cordoba, Departamento de Quimica Biologica, Facultad de Ciencias Quimicas, Universidad Nacional de Cordoba, Ciudad Universitaria, 5000 Cordoba, Argentina; Kekulé...
- Corresponding author
- Proia, Richard L.
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-03-10
- Volume
- 100
- Issue
- 6
- Pages
- 3445-3449
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC152312
- OpenAlex
- W2032416398
- Cited by
- 531
- References
- 20
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 12 · 2023: 16 · 2022: 29 · 2021: 16 · 2020: 31 · 2019: 22 · 2018: 24 · 2017: 18 · 2016: 23 · 2015: 22 · 2014: 28 · 2013: 29 · 2012: 31
- FWCI
- 6.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- GM3 ganglioside, GM3 synthase, insulin sensitivity, insulin resistance, insulin receptor phosphorylation, skeletal muscle, high-fat diet, type 2 diabetes, glycosphingolipids, sialic acid, mouse mutants
- MeSH terms
- Animals, Dietary Fats, G(M3) Ganglioside, Insulin Resistance, Mice, Inbred C57BL, Phosphorylation, Receptor, Insulin, Sialyltransferases, Signal Transduction, Mice, Knockout, Gene Targeting, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.